GLP-1 receptor agonist toxicity: Difference between revisions
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss | *GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss | ||
**Semaglutide | |||
**Liraglutide | |||
*Poison control centers have reported increasing inquiries related to possible overdoses | *Poison control centers have reported increasing inquiries related to possible overdoses | ||
Revision as of 20:22, 31 January 2024
Background
- GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss
- Semaglutide
- Liraglutide
- Poison control centers have reported increasing inquiries related to possible overdoses
Clinical Features
Differential Diagnosis
Evaluation
Workup
Diagnosis
Management
- Symptomatic management
- Anti-nausa medications (e.g., zofran)
- Consider stopping other glucose-lowering (i.e, diabetic) medications